Company Filing History:
Years Active: 2022-2025
Title: Innovations of Kui Chan in Biochemical Engineering
Introduction
Kui Chan is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biochemical engineering, particularly through his innovative patents. With a total of 3 patents, Chan's work focuses on the development of polypeptide variants and methods that have practical applications in various biochemical processes.
Latest Patents
Among his latest patents, Chan has developed variants of 3-hydroxybutyryl-CoA dehydrogenase. These patents provide detailed methodologies for the production of important biochemical products. The disclosures include thiolases and polypeptide variants, nucleic acids encoding these variants, and methods for culturing cells. The products derived from these innovations include 3-hydroxybutyryl-CoA (3-HB-CoA), 3-hydroxybutyraldehyde (3-HBal), 3-hydroxybutyrate (3-HB), and 1,3-butanediol (1,3-BDO), among others.
Career Highlights
Kui Chan is currently employed at Genomatica, Inc., where he continues to push the boundaries of biochemical research and innovation. His work has been instrumental in advancing the understanding and application of biochemical processes in various industries.
Collaborations
Chan collaborates with talented professionals in his field, including Kevin G Hoff and Cara Ann Tracewell. These collaborations enhance the innovative potential of his projects and contribute to the overall success of their research endeavors.
Conclusion
Kui Chan's contributions to biochemical engineering through his patents and collaborations highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has practical implications for various industries.